The healthcare sector is experiencing a surge in the use of artificial intelligence (AI), with projections indicating significant growth in the coming years. This growth is driven by collaborations and partnerships, the increasing prevalence of chronic diseases, and the implementation of AI technologies in radiology.
AI is playing a transformative role in drug discovery, enabling the pharmaceutical industry to identify potential drug candidates more efficiently and expedite the development of new treatments.
The integration of AI technologies holds the promise of improved patient outcomes and a more efficient healthcare system.
Major technology firms like Oracle, Microsoft, IBM, and Amazon Web Services, as well as specialized companies, are at the forefront of developing AI tools for drug discovery, improving patient outcomes, and streamlining healthcare operations.
Collaboration between healthcare institutions and technology companies is fostering an environment ripe for innovation.
Several trends are shaping the future of AI in healthcare, including its use in clinical trials, the treatment of rare diseases, and digital transformation within healthcare.
The integration of AI is becoming increasingly important as healthcare systems worldwide face challenges posed by an aging population and the need for cost-effective solutions.
The market is expected to reach $52.2 billion by 2028, driven by factors such as the adoption of precision medicine and the rising global cancer burden.